Iovance Biotherapeutics, Inc.

281 articles about Iovance Biotherapeutics, Inc.

• Genesis Biopharma, Inc. Retains Leading Strategic Consultancy The Emmes Group

  5/19/2011

• Genesis Biopharma, Inc. Forms Scientific and Medical Advisory Board

  5/18/2011

• Genesis Biopharma, Inc. Concludes Successful Presentation at Aegis Capital Emerging Growth Conference in Las Vegas

  5/2/2011

• Genesis Biopharma, Inc. to Present at Aegis Capital Emerging Growth Conference in Las Vegas on April 29

  4/14/2011

• Genesis Biopharma, Inc. Appoints William H. Andrews Ph.D. to Board of Directors

  3/17/2011

• Genesis Biopharma, Inc. Announces Plans to Develop Active Immunotherapy Platform

  3/16/2011

• Genesis Biopharma, Inc. to Present at the Roth Capital Growth Stock Conference on March 16

  3/9/2011

• Genesis Biopharma, Inc. Names Marvin S. Hausman M.D. as Chief Science Officer

  3/7/2011

• Genesis Biopharma, Inc. Appoints L. Stephen Coles M.D., Ph.D. to Board of Directors

  2/23/2011

• Genesis Biopharma, Inc. to Present at the Lippert/Heilshorn Life Sciences and Medtech Virtual Conference on February 17

  2/14/2011

• Genesis Biopharma, Inc. Announces Management and Board Changes

  2/11/2011

• Genesis Biopharma, Inc. Announces Anthony Cataldo Named President, CEO and Director

  2/11/2011

• Genesis Biopharma, Inc. Expresses Support for FDA Codevelopment Guidelines

  1/24/2011

• Genesis Biopharma, Inc. to Present at 2011 Biotech Showcase Conference

  1/6/2011

• Genesis Biopharma, Inc. Raises $845,000 in Private Financings

  1/4/2011

• Genesis Biopharma, Inc. CEO Interviewed on CorporateProfile.com

  11/12/2010

• Genesis Biopharma, Inc. Forms Genesis ADP to Promote Drug Development Collaborations

  11/10/2010

• Genesis Biopharma, Inc. Announces Issuance of European Patent for Anti-CD55 Targeted Cancer Therapy

  11/4/2010

• Genesis Biopharma, Inc. to Present at the Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13

  10/11/2010

• Genesis Biopharma, Inc. Announces $700K Private Financing

  9/23/2010